Comprehensive tissue deconvolution of cell-free DNA by deep learning for disease diagnosis and monitoring
Open Access
- 3 July 2023
- journal article
- research article
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 120 (28)
Abstract
Plasma cell-free DNA (cfDNA) is a noninvasive biomarker for cell death of all organs. Deciphering the tissue origin of cfDNA can reveal abnormal cell death because of diseases, which has great clinical potential in disease detection and monitoring. Despite the great promise, the sensitive and accurate quantification of tissue-derived cfDNA remains challenging to existing methods due to the limited characterization of tissue methylation and the reliance on unsupervised methods. To fully exploit the clinical potential of tissue-derived cfDNA, here we present one of the largest comprehensive and high-resolution methylation atlas based on 521 noncancer tissue samples spanning 29 major types of human tissues. We systematically identified fragment-level tissue-specific methylation patterns and extensively validated them in orthogonal datasets. Based on the rich tissue methylation atlas, we develop the first supervised tissue deconvolution approach, a deep-learning-powered model, cfSort , for sensitive and accurate tissue deconvolution in cfDNA. On the benchmarking data, cfSort showed superior sensitivity and accuracy compared to the existing methods. We further demonstrated the clinical utilities of cfSort with two potential applications: aiding disease diagnosis and monitoring treatment side effects. The tissue-derived cfDNA fraction estimated from cfSort reflected the clinical outcomes of the patients. In summary, the tissue methylation atlas and cfSort enhanced the performance of tissue deconvolution in cfDNA, thus facilitating cfDNA-based disease detection and longitudinal treatment monitoring.Keywords
Funding Information
- HHS | NIH | National Cancer Institute (U01CA230705)
- HHS | NIH | National Cancer Institute (R01CA246329)
- HHS | NIH | National Cancer Institute (U01CA237711)
- HHS | NIH | National Cancer Institute (R01CA264864)
- National Science Foundation (DMS1952386)
- HHS | National Institutes of Health (R01HG010359)
- HHS | National Institutes of Health (P50HG007735)
- V Foundation for Cancer Research (NA)
- HHS | NIH | National Cancer Institute (R01CA246304)
- HHS | NIH | National Cancer Institute (R01CA253651)
This publication has 42 references indexed in Scilit:
- ENCODE data at the ENCODE portalNucleic Acids Research, 2015
- Plasma DNA tissue mapping by genome-wide methylation sequencing for noninvasive prenatal, cancer, and transplantation assessmentsProceedings of the National Academy of Sciences, 2015
- Integrative analysis of 111 reference human epigenomesNature, 2015
- Transcription factor binding dynamics during human ES cell differentiationNature, 2015
- Correlation between cell free DNA levels and medical evaluation of disease progression in systemic lupus erythematosus patientsCellular Immunology, 2014
- DNA methylome profiling of human tissues identifies global and tissue-specific methylation patternsGenome Biology, 2014
- Noninvasive detection of cancer-associated genome-wide hypomethylation and copy number aberrations by plasma DNA bisulfite sequencingProceedings of the National Academy of Sciences, 2013
- The Genotype-Tissue Expression (GTEx) projectNature Genetics, 2013
- Simple Combinations of Lineage-Determining Transcription Factors Prime cis-Regulatory Elements Required for Macrophage and B Cell IdentitiesMolecular Cell, 2010
- Reduced representation bisulfite sequencing for comparative high-resolution DNA methylation analysisNucleic Acids Research, 2005